Boldenone undecylenate

CAS No. 13103-34-9

Boldenone undecylenate( Boldenone 10-Undecenoate )

Catalog No. M11241 CAS No. 13103-34-9

A synthetic, anabolic-androgenic steroid (AAS) and androgen ester that is used in veterinary medicine, a long-acting ester of boldenone.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 36 Get Quote
5MG 43 Get Quote
10MG 69 Get Quote
25MG 129 Get Quote
50MG 233 Get Quote
100MG 375 Get Quote
200MG Get Quote Get Quote
500MG 889 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Boldenone undecylenate
  • Note
    Research use only, not for human use.
  • Brief Description
    A synthetic, anabolic-androgenic steroid (AAS) and androgen ester that is used in veterinary medicine, a long-acting ester of boldenone.
  • Description
    A synthetic, anabolic-androgenic steroid (AAS) and androgen ester that is used in veterinary medicine, a long-acting ester of boldenone.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Boldenone 10-Undecenoate
  • Pathway
    Endocrinology/Hormones
  • Target
    Androgen Receptor (AR)
  • Recptor
    AndrogenReceptor
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    13103-34-9
  • Formula Weight
    452.6685
  • Molecular Formula
    C30H44O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 41 mg/mL
  • SMILES
    O=C(C=C1)C=C2[C@@]1(C)[C@@H](CC[C@@]3(C)[C@H]4CC[C@@H]3OC(CCCCCCCCC=C)=O)[C@H]4CC2
  • Chemical Name
    Androsta-1,4-dien-3-one, 17-[(1-oxo-10-undecenyl)oxy]-, (17β)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Dornelles GL, et al. Mol Cell Biochem. 2017 Jan;425(1-2):181-189. 2. Oda SS, et al. Int J Exp Pathol. 2012 Jun;93(3):172-8.
molnova catalog
related products
  • ARV-110

    ARV-110 is an oral degrader of androgen receptor PROTAC for prostate cancer treatment.

  • Flutamide

    Flutamide is an antiandrogen drug, with its active metablolite binding at androgen receptor.

  • UT-34

    UT-34 is a selective and orally active antagonist of second-generation pan-androgen receptor (AR) and degrader(IC50s of 211.7 nM, 262.4 nM and 215.7 nM for wild-type, F876L and W741L AR, respectively), and has anti-prostate cancer efficacy. In LNCaP cells, UT-34 (3-10 μM; 24 hours) treatment inhibits the expression of PSA and FKBP5 and growth of LNCaP cells starting from 100 nM with maximum effect observed at 10 μM.